Enalapril

ATC Code C09AA02

Enalapril

Definition

A dicarbocyl-containing peptide and angiotensin-converting enzyme (ACE) inhibitor with antihypertensive activity. As a prodrug, enalapril is converted by de-esterification into its active form enalaprilat. Enalaprilat competitively binds to and inhibits ACE, thereby blocking the conversion of angiotensin I to angiotensin II. This prevents the potent vasoconstrictive actions of angiotensin II and results in vasodilation. Enalapril also decreases angiotensin II-induced aldosterone secretion by the adrenal cortex, which leads to an increase in sodium excretion and subsequently increases water outflow.

Also known as ENALAPRIL — per NCIT

Also identified as

Indications

Disease Relation Source
Diabetic kidney disease may prevent MEDRT · Public domain (U.S. Government work)
Bartter syndrome may treat MEDRT · Public domain (U.S. Government work)
Diabetic kidney disease may treat MEDRT · Public domain (U.S. Government work)
Heart failure may treat MEDRT · Public domain (U.S. Government work)
Malignant hypertension may treat MEDRT · Public domain (U.S. Government work)
Rheumatoid arthritis may treat MEDRT · Public domain (U.S. Government work)

Organ Effects

Organ Side effect / interaction Source
Adult mammalian kidney may treat a disease of this organ DERIVED · CC BY 4.0
Bone element may treat a disease of this organ DERIVED · CC BY 4.0
Cardiovascular system may treat a disease of this organ DERIVED · CC BY 4.0
Genitourinary system may treat a disease of this organ DERIVED · CC BY 4.0
Heart may treat a disease of this organ DERIVED · CC BY 4.0
Musculoskeletal system may treat a disease of this organ DERIVED · CC BY 4.0
Renal system may treat a disease of this organ DERIVED · CC BY 4.0
Skeletal joint may treat a disease of this organ DERIVED · CC BY 4.0

8 entries above are marked DERIVED: Atlas Médico inferred them by combining two sourced claims, and no source asserts these links directly. Treat them as a navigation aid, not as a clinical statement.